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Abstract
The pineal gland, a circumventricular organ, plays an integrative role in defense responses. The injury-induced suppression
of the pineal gland hormone, melatonin, which is triggered by darkness, allows the mounting of innate immune responses.
We have previously shown that cultured pineal glands, which express toll-like receptor 4 (TLR4) and tumor necrosis factor
receptor 1 (TNFR1), produce TNF when challenged with lipopolysaccharide (LPS). Here our aim was to evaluate which cells
present in the pineal gland, astrocytes, microglia or pinealocytes produced TNF, in order to understand the interaction
between pineal activity, melatonin production and immune function. Cultured pineal glands or pinealocytes were
stimulated with LPS. TNF content was measured using an enzyme-linked immunosorbent assay. TLR4 and TNFR1 expression
were analyzed by confocal microscopy. Microglial morphology was analyzed by immunohistochemistry. In the present
study, we show that although the main cell types of the pineal gland (pinealocytes, astrocytes and microglia) express TLR4,
the production of TNF induced by LPS is mediated by microglia. This effect is due to activation of the nuclear factor kappa B
(NF-kB) pathway. In addition, we observed that LPS activates microglia and modulates the expression of TNFR1 in
pinealocytes. As TNF has been shown to amplify and prolong inflammatory responses, its production by pineal microglia
suggests a glia-pinealocyte network that regulates melatonin output. The current study demonstrates the molecular and
cellular basis for understanding how melatonin synthesis is regulated during an innate immune response, thus our results
reinforce the role of the pineal gland as sensor of immune status.
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Introduction
The pineal gland, a circumventricular organ, plays an
integrative role in the neuro-endocrine-immune response [1–3].
In mammals, the major cellular component of the pineal gland is
the pinealocyte. In rats, this cell type comprises around 90% of the
gland and the remainder consists mainly of glial cells and nerve
fibers [4]. The pinealocytes are responsible for synthesizing
melatonin, the darkness hormone, while the functions of astrocytes
and microglia in the pineal gland are currently unclear.
The pineal gland only synthesizes melatonin at night due to
nocturnal gene transcription and an increase in the activity of the
enzyme arylalkylamine-N-acetyltransferase (AA-NAT) induced by
noradrenaline activation of beta-adrenoceptors [5–7]. The daily
rhythm of melatonin is driven by pineal production. Gastroin-
testinal cells, immunocompetent cells, and astrocytes also
synthesize melatonin, which plays a local role related to tissue
protection [8–16].
The pineal and extrapineal sources of melatonin production
have been linked to independent physiological or pathophysio-
logycal contexts. Pineal melatonin, the darkness hormone, is
responsible for effects dependent on low levels (pM range) of the
indolamine, whereas extrapineal melatonin acts as a paracrine
or autocrine mediator reaching higher concentrations (mM
range) [1]. ‘Chronobiotic’ levels of melatonin inhibit both the
rolling and adherence of leukocytes to the endothelial layer, and
reduce vascular permeability [17,18], avoiding unnecessary
innate immune responses. In order to develop a full innate
immune response, nocturnal pineal melatonin synthesis is
suppressed both in birds and mammals [1,19,20]. In addition,
immune-competent cells present in inflamed tissues are stimu-
lated to synthesize melatonin, which acts in a paracrine manner
as an anti-inflammatory mediator [1,9,11,16]. This new
approach in interpreting data regarding the two main functions
of melatonin suggests that it is necessary to stop translating
environmental lighting changes to the body, in order to allow
the induction of inflammatory responses, which are essential for
proper healing.
Prolonged disruption of chronobiotic pineal function correlates
with several pathologies. An understanding of the mechanistic
basis involved in the suppression of pineal melatonin synthesis
during induction of innate immune responses will provide new
insights in the relationship between the temporal organization of
physiological functions and the genesis and maintenance of the
pathological status.
PLoS ONE | www.plosone.org 1 July 2012 | Volume 7 | Issue 7 | e40142Recently we have reported that the rat pineal gland responds to
lipopolysaccharide (LPS), an endotoxin found in the outer
membrane of gram-negative bacteria. This pathogen-associated
molecular pattern triggers the activation of the transcription factor
nuclear factor kappa B (NF-kB). In the pineal gland, LPS induces a
rapid and transient activation of this pathway that can suppress
melatonin synthesis [21]. In addition, LPS also triggers TNF
production in vitro [21]. TNF inhibits melatonin synthesis by
blocking AA-NAT gene transcription in cultured rat pineal glands
[22]. High levels of TNF correlate with the inhibition of nocturnal
melatonin in humans [11,12,23]. Furthermore, TNF is one of the
first pro-inflammatory agents produced at the beginning of an
immune response and amplifies and prolongs inflammatory
responses. In the rat pineal gland, TNF is recognized by TNFR1
expressed on astrocytes, microglia and pinealocytes [24]. Howev-
er, the source of TNF production in cultured pineal glands is
currently unknown.
The aim of the present study was to elucidate the mechanism of
action of LPS in the pineal gland, by evaluating its effect on
different cell types. Therefore, we evaluated the localization of
LPS receptors in different pineal gland cell types, and the
downstream activation of NF-kB nuclear translocation which
results in TNF synthesis. In addition, we analyzed the mechanism
involved in the control of melatonin synthesis by LPS. Our data
show that TLR4 is expressed on microglia, astrocytes and
pinealocytes. In addition, we demonstrated that LPS induced
microglial activation and TNF production, which may interact
with TNFR1 that is up-regulated on pinealocytes. Our data also
highlight the relevance of the NF-kB pathway in regulating
melatonin synthesis. In this context, the production of TNF by
microglia indicates an additional mechanism for controlling
melatonin output and suggests a glia-pinealocyte regulatory
network during inflammation. Therefore, we reinforce the
hypothesis that the pineal gland is a sensor of immune status
and provide a molecular basis that explains how melatonin
synthesis is suppressed, as observed during clinical and experi-
mental inflammatory conditions.
Methods
Animals
Pre-pubertal male and female Wistar rats (6 weeks, 84 animals)
from the animal facility of the Department of Physiology (IB-USP,
Sa ˜o Paulo, Brazil), were kept under a 12/12 h light/dark cycle
(lights on at 07h00, considered as Zeitgeber time zero (ZT 0)) and
received water and food ad libitum. The animals were killed by
decapitation at ZT 6. All experiments were carried out in
compliance with ethical standards of our institutional ethical
committee (CEUA/IB-USP: license number 045/2007) and with
the recommendation of the National Council on Experimental
Animal Control (CONCEA).
Drugs
Lipopolysaccharide (LPS, from E. coli serotype 0127:B8),
penicillin/streptomycin, HEPES, BGJb medium and bovine
albumin fraction V, minocycline hydrochloride, N-acetyl-leuci-
nyl-leucinyl-norleucinal-H (ALLN), DL-fluorocitric acid barium
salt, trypsin and trypsin inhibitor were obtained from Sigma (St
Louis, MO, USA); Dulbecco’s Modified Eagle Medium (DMEM),
and 6-diamidino-2-phenylindole (DAPI) were obtained from
Invitrogen (Carlsbad, CA, USA); DL-fluorocitric acid barium salt
was prepared as referenced [25]. Minocycline, ALLN and LPS
were diluted directly in the medium.
Organ Culture
Freshly-removed rat pineal glands were incubated (37uC, 95%
O2,5 %C O 2, 48 h) in BGJb medium enriched with 2 mM
glutamine, 100 U/mL penicillin and 10 mg/mL streptomycin
(pH 7.4) in a 24-multiwell plate (1 gland per well, 200 mLo f
medium per well), as previously described [26]. The medium was
replaced every 24 h.
Pinealocyte Culture
Primary pinealocyte cultures were prepared from rat pineal
glands as previously described [27], with some modifications.
Briefly, pinealocytes were obtained by trypsinization (0.25%,
37uC, 15 min) followed by mechanical dispersion in the presence
of trypsin inhibitor (0.3%) in a solution containing mmol/L
quantities of the following: 120 NaCl, 5 KCl, 25 NaHCO3,
1.2 KH2PO4, 12 glucose and 0.1% w/v bovine serum albumin.
After centrifugation (15 min, 10006g), the cells were resuspended
in DMEM supplemented with 100 U/mL penicillin and 100 mg/
mL streptomycin (pH 7.4). The total number of cells and
fractional survival was estimated by Trypan blue exclusion. The
survival rate was 90% or higher. Cells (0.7 610
5) were seeded on
poly-L-lysine coated 8-well chamber plate and maintained at
37uC, 5% CO2 for 18 h prior to experimental analysis.
In vitro Treatments
The effect of LPS (0.1 mg/mL) on microglial activity and
TNFR1 expression were determined in cultured pineal glands,
and pinealocytes, respectively. The induction of TNF by LPS was
determined both in gland and cell cultures. Microglial and
astrocyte activity was blocked with minocycline (1 to 300 mM, 1 h)
or fluorocitrate (1 to 300 mM, 1 h), respectively. The NF-kB
pathway was blocked with ALLN (12.5 mM) 48 h prior to LPS
stimulation of cultured pineal glands. The control for each
experiment consisted of incubation with the vehicle solution of
each drug used. The medium was stored for no longer than one
month at –20uC before determining the concentration of TNF by
ELISA.
Immunohistochemistry
The expression of TLR4 and double-labeling of TLR4 with
ED-1 or GFAP were performed by immunohistochemistry assay
as previously described [21] in frozen sections o pineal glands
obtained from animals killed at ZT 6. Briefly, animals were
anesthetized by intramuscular injection of ketamine (160 mg/kg)
and xylazine (40 mg/kg) and perfused transcardially with 150 mL
of saline followed by 300 mL of cold 4% paraformaldehyde,
pH 9.5. Each pineal gland was removed from the skull and
maintained at 4uC for 24 h in PBS plus 20% sucrose. Pineal
glands were then embedded in medium for frozen tissue specimens
(Tissue-Tek, Sakura Finetek, Torrance, CA, USA), frozen in dry
ice and stored at –80uC till processing. Cryostat sections cut at a
thickness of 20 mm were fixed in 4% paraformaldehyde (30 min,
pH 9.5) and were incubated with 0.1 M glycine (5 min) followed
by 1% albumin and 0.01% saponin in PBS (1 h, room
temperature). Endogenous biotin was blocked using the Avidin-
Biotin Blocking kit as suggested by the manufacturer (Vector
Laboratories, SP2001, Burlingame, CA, USA). Rabbit polyclonal
antibody anti-TLR4 (1:200, Abcam, Cambridge, MA, USA) was
incubated for 48 h at 4uC followed by incubation with an
appropriate secondary antibody conjugated with FITC (1:200,
Sigma) for 1 h at room temperature. Next, the sections were
incubated with 0.1 M glycine (5 min) followed by 1% albumin and
0.01% saponin in PBS (1 h, room temperature) and then
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astrocytes (mouse monoclonal Cy3-conjugated GFAP, 1:500,
Sigma) or microglia (mouse monoclonal anti-ED-1, 1:100, Abcam)
followed by the appropriate secondary antibody conjugated with
Cy3 (1:200, Jackson ImmunoResearch, West Grove, PA, USA).
All procedures were repeated at least 3 times to confirm the results.
Images were acquired by a Confocal Laser-scanning microscope
with a 406or 1006objective and Zeiss LSM 510 (Zeiss confocal
software, Germany). FITC was excited at 488 nm (Argon laser)
and emitted fluorescence was measured at 515–530 nm. Cy3 was
excited at 543/633 nm (HeNe laser) and emitted fluorescence was
measured at 560 nm. An enterprise laser (excitation 364 nm and
emission filter of 435–485 nm) was used for 49, 6-diamidino-2-
phenylindole (DAPI) imaging.
For microglial reactivity analysis, the pineal glands were
cultured and incubated with LPS (0.1 mg/mL, 2 h). The cultured
glands were fixed in 4% cold paraformaldehyde, pH 9.5 for 3 days
at 4uC, followed by 24 h incubation in PBS plus 20% sucrose.
Pineal glands were then frozen and the immunohistochemistry
assay was performed as described previously by incubation with
primary antibody (mouse monoclonal anti-ED-1, 1:100, Abcam)
followed by the secondary antibody conjugated with biotin (1:200,
Sigma). The peroxidase activity was revealed with 3, 39-
diaminobenzidine (DAB substrate kit for Peroxidase, Vector
Laboratories). Photomicrographs were obtained from bright-field
microscope (Nikon Eclipse E1000 coupled to a CoolSNAP-Pro
Color digital camera) using the Image-ProH Plus software (Media
Cybernetics, Silver Spring, MD, USA).
The negative controls were performed by omission of the
primary antibodies from the procedures and the substitution of
normal serum from the same species. Staining was completely
abolished under these conditions.
Immunocytochemistry
The immunocytochemistry assay was performed as previously
described [21]. Briefly, cultured pinealocytes were fixed in 4%
cold paraformaldehyde for 10 min and permeabilized with PBS
plus saponin 0.5% at room temperature. The non-specific binding
sites were blocked with 1% bovine serum albumin fraction V
(BSA) and 0.3 M glycine for 60 min. The cells were then
incubated with primary rabbit polyclonal antibody anti-TNFR1
(1:500, Abcam), anti-CD14 (1:200, Abcam) or anti-TLR4 (1:500,
Abcam) for 18 h at 4uC, followed by secondary polyclonal anti-
rabbit conjugated with Texas Red antibody (1:400, Abcam) or
FITC (1:200, Sigma) for 1 h at room temperature. Nuclei were
stained with DAPI (300 mM, 5 min) at room temperature. Primary
and secondary antibodies were diluted in blocking buffer. Images
were acquired by a Confocal Laser-scanning microscope with a
40 6oil-immersion objective and Zeiss LSM 510 (Zeiss confocal
software, Germany) using a HeNe 543/633 laser for Texas Red
(excitation 590 nm; emission filter 650 nm), and enterprise laser at
excitation 364 nm and emission filter of 435–485 nm for DAPI
imaging. Fluorescence was quantified by Image J Software
(http://rsb.info.nih.gov/ij).
The negative controls were performed by omission of the
primary antibodies from the procedures and the substitution of
normal serum from the same species. Staining was completely
abolished under these conditions.
Figure 1. Cellular expression of TLR4 in the rat pineal gland.
Representative images of TLR4 co-localization in astrocytes (A-D) and
microglia (F-I). Green staining (A-E and F-I) represents immunoreactivity
of TLR4. Red staining (B and G) represents immunoreactivity of GFAP (B)
or ED-1 (G). Merged images (C, D, H and I) indicate co-localization of
TLR4 and glia staining (double-arrow). As 90% of the pineal gland is
composed by pinealocytes, the adjacent staining of TLR4 suggests
expression in this cell type (single arrow). In order to confirm this result
we performed immunocytochemistry assays and detected constitutive
expression of TLR4 (E) and CD14 (J) in isolated pinealocytes. D and I
correspond to the higher magnification of C and H, respectively (1006
objective). The nuclei were stained with DAPI (blue).
doi:10.1371/journal.pone.0040142.g001
Glia-Pinealocyte Network
PLoS ONE | www.plosone.org 3 July 2012 | Volume 7 | Issue 7 | e40142TNF Detection
TNF concentration in the medium was measured with a
commercially available rat TNF-alpha ELISA Ready-set-go kit
(cat. 88-7340, eBioscience, San Diego, USA).
Statistical Analysis
Data are presented as the mean 6 S.E.M. Statistical analysis
was performed using the student’s t test or ANOVA followed by
Newman-Keuls test. Values of P,0.05 were considered statisti-
cally significant.
Results
Cellular Distribution of TLR4 in the Rat Pineal Gland
TLR4 expression was detected by immunohistochemistry in
frozen pineal gland sections from rats perfused at ZT 6. TLR4-
positive immunostaining was diffusely observed in the pineal
parenchyma [21]. In order to evaluate the cell type that expressed
TLR4 in the gland we double-labeled the receptor with glial
markers or cultured isolated pinealocytes for immunocytochem-
istry. Here we used ED-1 (CD68, Cluster of Differentiation 68) or
GFAP (Glial Fibrillary Acidic Protein) for double-staining TLR4
Figure 2. LPS induces microglia activation in vitro. Representative immunohistochemistry image of frozen pineal sections stained with ED-1
(CD68) antibody. In control tissue, microglial cells are present as small cellular bodies with long branched processes, as expected in a resting or
surveillance state (single arrow). LPS changed the morphology of the microglia to cells with larger bodies and no branches, suggesting an activated
state (arrow head). n =3–4 glands. The experiments were repeated twice.
doi:10.1371/journal.pone.0040142.g002
Figure 3. LPS induces TNF synthesis in cultured pineal glands dependent on microglia activation and NF-kB activity. A) The effect of
blocking microglia (circles, minocycline, 1 to 300 mM, 1 h) or astrocyte activation (triangles, fluorocitrate, 1 to 300 mM, 1 h) on TNF levels. As observed,
minocycline or fluorocitrate per se (open symbols) does not induce TNF production in cultured pineal glands. Values obtained in the absence of the
inhibitors (control, C) are also plotted. Minocycline, but not fluorocitrate, blocks LPS-induced (closed symbols) TNF production in a concentration-
dependent manner. These data indicate that microglial cells are the pivotal producers of TNF in the rat pineal gland. The data are expressed as the
mean 6 S.E.M. of 12–14 glands per point obtained in three different experiments. B) The effect of blocking the NF-kB pathway on TNF production. As
observed, ALLN (12.5 mM, 48 h) fully abolished the LPS-induced TNF synthesis in cultured rat pineal gland. The data are expressed as the mean 6
S.E.M., n =4–5 glands obtained in two different experiments. N.D. = not detected.
doi:10.1371/journal.pone.0040142.g003
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staining co-localized with both astrocyte (GFAP, Fig. 1A-D) and
microglia (ED-1, Fig. 1F-I) markers, and was present on isolated
pinealocytes (Fig. 1E), indicating that these three cell types present
in the pineal gland express TLR4 and are able to respond to LPS.
We also detected constitutive expression of CD14 (Cluster of
Differentiation 14) in isolated pinealocytes (Fig. 1J).
Microglia Mediate LPS-induced TNF Production
Microglial reactivity was evaluated by immunohistochemistry in
frozen sections of cultured pineal glands stimulated with LPS
(0.1 mg/mL, 2 h) and stained with ED-1. Microglial cells were
diffusely distributed in the pineal parenchyma (Fig. 2). In control
glands, microglial cells were present as small cellular bodies with
long branched processes, as expected in a resting or surveillance
state. In LPS-treated pineal glands, the microglia cells present
larger bodies and no branches suggestive to an activated state [28].
Isolated pinealocytes incubated with LPS (0.1 mg/mL, 0 to 6 h)
did not produce detectable amounts of TNF in the medium,
suggesting that other cell types produce this cytokine. The
inhibition of microglia by minocycline, but not of astrocytes by
fluorocitrate, inhibited LPS-induced pineal gland synthesis of
TNF, indicating that microglia were the major cell type that
synthesized this cytokine (Fig. 3A).
As seen in other immune defense cells [29], TNF production in
the cultured pineal glands was mediated by activation of the NF-
kB pathway. LPS-induced TNF production was blocked by
ALLN, a classical inhibitor of proteasomes (Fig. 3B).
LPS Regulates TNFR1 Expression in Isolated Pinealocytes
The time-course of the LPS effect on TNFR1 expression on
isolated pinealocytes was determined after 15, 30, 120 and
240 min of stimulation. LPS induced a bimodal regulation of
TNFR1 expression. Between 30 and 120 min, a down regulation
was observed, while in the interval between 120 and 240 min
there was an up-regulation (Fig. 4).
Discussion
The pineal gland, besides being the neuro-endocrine transducer
of daily dark/light cycles, also plays a relevant role in regulating
immune responses. Besides producing melatonin, the pineal gland
can also be induced to synthesize several cytokines, such as such as
transforming growth factor-beta1, interleukin-6, interleukin-1-beta
and TNF [21,30–32]. The understanding of the relationship
between the synthesis of melatonin and cytokines by pineal glands
challenged with danger signals is in the center of the questions
regarding the role of pineal gland in an innate immune response.
The present paper focused on demonstrating that the microglia
present in the pineal gland, instead of astrocytes or even
pinealocytes are the cells that answer to LPS for synthesizing TNF.
A rise in nocturnal melatonin is one of the mechanisms that
inhibit leukocyte migration to healthy tissues [33]. Reduction of
nocturnal plasma melatonin, a prerequisite for the proper
induction of an inflammatory response, is based on the ability of
the pineal gland to detect and respond to danger signals. We have
previously shown that intravenous LPS injection significantly
reduces plasma melatonin at night, and increases the expression of
adhesion molecules by endothelial cells [34]. In addition, LPS
reduces noradrenaline-induced melatonin synthesis by triggering
the NF-kB pathway through activation of TLR4 [21].
Besides modulating melatonin synthesis, LPS triggers the pineal
synthesis of TNF, detectable in the culture medium after 2 h and
attaining a maximal concentration after 4 h of incubation [21].
We observed that pinealocytes, astrocytes and microglia expressed
TLR4, and therefore could be directly activated by LPS, as
suggested by the activation of microglia after intravenous injection
of LPS [35] or by in vitro incubation (present work). Other
circumventricular organs, such as the organum vasculosum of the
lamina terminalis, area postrema, choroid plexus, meninges,
subfornincal organ and median eminence also express TLR4
[36,37]. Therefore, besides the pinealocytes, microglia and
astrocytes are also able to respond to LPS, raising the question
of whether TNF is synthesized by one specific cell type.
As isolated pinealocytes were not able to synthesize detectable
amounts of TNF, we focused on the glial cells. The pharmaco-
logical inhibition of astrocytes or microglia indicated that only
pineal gland microglial cells were able to produce TNF. This
correlated with observed effects of LPS administration in the
central nervous system, as the rolling and adhesion of leukocytes
and TNF production are blocked by minocycline [38], an
inhibitor of microglia activation that inhibits TNF synthesis in
several areas of the central nervous system. Although astrocytes
are known to synthesize TNF when stimulated with LPS, our data
show that under the experimental conditions of the present study,
no TNF is produced by pineal gland astrocytes.
TLR4 signal transduction occurs mainly through NF-kB, an
important downstream signaling pathway for controlling physio-
logical and pathophysiological conditions [39–41] and a master
modulator of cytokine production [42]. NF-kB acts as either a
repressor or inductor of gene transcription. Usually the homodi-
mer p50/p50, which lacks a transactivating domain, represses
gene transcription while the heterodimer p50/RelA induces gene
transcription [43]. We have previously demonstrated that LPS
induced the nuclear translocation of p50/p50 and p50/RelA
dimers in the rat pineal gland [21]. As melatonin is synthesized by
pinealocytes, and these cells express TLR4 we concluded that
activation of the NF-kB pathway in pinealocytes inhibited
Figure 4. LPS modulates TNFR1 expression in pinealocytes.
Quantitative analyses performed through ImageJ software demonstrat-
ed that LPS (0.1 mg/mL) induced the down-regulation of TNFR1 after
30 min and 2 h of incubation and up-regulation of TNFR1 after 4 h
incubation. The data are expressed as the mean 6 S.E.M. of the %
relative to control samples from 80 cells obtained in 4 different
experiments.
doi:10.1371/journal.pone.0040142.g004
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p50/p50 homodimer, while TNF production is dependent on the
activation of the p50/RelA heterodimer in microglia, as it is
inhibited by minocycline and ALLN. In summary, we concluded
that LPS acts on pinealocytes and microglia, impairing the
production of melatonin, and inducing the synthesis of TNF,
respectively.
As activation of TNFR1 impairs noradrenaline-induced mela-
tonin synthesis [22,24] this strongly suggests that TNF produced
by microglia amplifies the LPS-effect mediated by activation of
TLR4 on pinealocytes. It is interesting to note that the peak of
TNF production by microglia [21] and the maximal TNFR1
expression attained in pinealocytes (present paper) occurred
240 min after incubation of pineal glands with LPS. This fine-
tuning between the timing of agonist production and expression of
the receptor suggests that the amplification of the LPS effect by
TNF represents a second activation of the nuclear translocation of
NF-kB. Reinforcing the idea of this strict control in the timing of
the response, LPS initially induced a reduction in pinealocyte
expression of TNFR1 (from 30 to 120 min). It is interesting to note
that in mouse bone marrow granulocytes, receptor shedding
induced by LPS reduced the expression of TNFR1 over a similar
time-course (20 min), by a p38 mitogen-activated protein kinase
dependent mechanism [44], a signaling cascade known to
participate in control of the amplitude and duration of the
nocturnal peak of the key enzyme in melatonin synthesis [45].
Therefore, the initial reduction of TNFR1 receptors also favors the
idea that the peak of NF-kB activation in pinealocytes induced by
TNF is programmed to occur after the initial wave triggered by
direct LPS activation of TLR4 [29,46].
The relevance of pineal production of TNF is currently unclear,
although TNF can inhibit noradrenaline-induced transcription of
AA-NAT and the synthesis of N-acetylserotonin [22,24]. This
mechanism is also important for controlling the nocturnal
melatonin surge in humans. The suppression of the nocturnal
melatonin surge in innate immune responses to mastitis [11] or
surgery incision [12] is inversely correlated with TNF. In addition,
it was observed that the return of nocturnal melatonin pineal
output was strictly dependent upon the conclusion of the TNF
peak [30].
In conclusion, (Fig. 5), the pineal gland is a target for LPS, as
TLR4 is expressed on pinealocytes, astrocytes and microglia. The
effect of LPS on pinealocytes, the effector cells of the pineal gland,
occur not only by direct stimulation of TLR4, but also by inducing
TNF production in microglia. In addition, the expression of
TNFR1 on pinealocytes is under fine-tuned temporal control.
Finally, the complexity of LPS effects on the pineal gland provides
the first insight into strategies that can ensure proper control of the
expression of circadian timing during the evolution of an innate
immune response.
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